nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0343	0.0493	CbGbCtD
Valproic Acid—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0332	0.0477	CbGbCtD
Valproic Acid—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0311	0.0446	CbGbCtD
Valproic Acid—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0268	0.0386	CbGbCtD
Valproic Acid—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0251	0.0361	CbGbCtD
Valproic Acid—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.019	0.0273	CbGbCtD
Valproic Acid—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0186	0.0267	CbGbCtD
Valproic Acid—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0176	0.0253	CbGbCtD
Valproic Acid—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0175	0.0251	CbGbCtD
Valproic Acid—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0175	0.0251	CbGbCtD
Valproic Acid—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0158	0.0227	CbGbCtD
Valproic Acid—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0138	0.0198	CbGbCtD
Valproic Acid—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.019	CbGbCtD
Valproic Acid—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0132	0.019	CbGbCtD
Valproic Acid—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0124	0.0179	CbGbCtD
Valproic Acid—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0124	0.0179	CbGbCtD
Valproic Acid—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0172	CbGbCtD
Valproic Acid—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.012	0.0172	CbGbCtD
Valproic Acid—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.012	0.0172	CbGbCtD
Valproic Acid—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0118	0.017	CbGbCtD
Valproic Acid—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0111	0.016	CbGbCtD
Valproic Acid—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0109	0.0157	CbGbCtD
Valproic Acid—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0107	0.0154	CbGbCtD
Valproic Acid—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0104	0.015	CbGbCtD
Valproic Acid—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0102	0.0147	CbGbCtD
Valproic Acid—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0102	0.0147	CbGbCtD
Valproic Acid—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0102	0.0147	CbGbCtD
Valproic Acid—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.01	0.0144	CbGbCtD
Valproic Acid—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.01	0.0144	CbGbCtD
Valproic Acid—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00982	0.0141	CbGbCtD
Valproic Acid—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00943	0.0136	CbGbCtD
Valproic Acid—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00943	0.0136	CbGbCtD
Valproic Acid—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00926	0.0133	CbGbCtD
Valproic Acid—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00923	0.0133	CbGbCtD
Valproic Acid—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00923	0.0133	CbGbCtD
Valproic Acid—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00907	0.013	CbGbCtD
Valproic Acid—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00907	0.013	CbGbCtD
Valproic Acid—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0087	0.0125	CbGbCtD
Valproic Acid—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00867	0.0125	CbGbCtD
Valproic Acid—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00841	0.0121	CbGbCtD
Valproic Acid—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00835	0.012	CbGbCtD
Valproic Acid—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00835	0.012	CbGbCtD
Valproic Acid—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00776	0.0112	CbGbCtD
Valproic Acid—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00761	0.0109	CbGbCtD
Valproic Acid—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00761	0.0109	CbGbCtD
Valproic Acid—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00729	0.0105	CbGbCtD
Valproic Acid—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00721	0.0104	CbGbCtD
Valproic Acid—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00702	0.0101	CbGbCtD
Valproic Acid—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00699	0.0101	CbGbCtD
Valproic Acid—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00633	0.00909	CbGbCtD
Valproic Acid—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00633	0.00909	CbGbCtD
Valproic Acid—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00606	0.00872	CbGbCtD
Valproic Acid—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00571	0.0082	CbGbCtD
Valproic Acid—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00537	0.00771	CbGbCtD
Valproic Acid—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00537	0.00771	CbGbCtD
Valproic Acid—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00485	0.00698	CbGbCtD
Valproic Acid—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00485	0.00698	CbGbCtD
Valproic Acid—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00419	0.00602	CbGbCtD
Valproic Acid—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00407	0.00585	CbGbCtD
Valproic Acid—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00368	0.00529	CbGbCtD
Valproic Acid—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00368	0.00529	CbGbCtD
Valproic Acid—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00353	0.00507	CbGbCtD
Valproic Acid—OGDH—blood plasma—acquired immunodeficiency syndrome	0.00291	0.0376	CbGeAlD
Valproic Acid—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00237	0.0307	CbGeAlD
Valproic Acid—OGDH—retina—acquired immunodeficiency syndrome	0.00159	0.0206	CbGeAlD
Valproic Acid—UGT1A10—digestive system—acquired immunodeficiency syndrome	0.00152	0.0197	CbGeAlD
Valproic Acid—UGT1A6—digestive system—acquired immunodeficiency syndrome	0.00142	0.0183	CbGeAlD
Valproic Acid—UGT1A8—digestive system—acquired immunodeficiency syndrome	0.0012	0.0156	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—acquired immunodeficiency syndrome	0.00113	0.0146	CbGeAlD
Valproic Acid—OGDH—digestive system—acquired immunodeficiency syndrome	0.00112	0.0145	CbGeAlD
Valproic Acid—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00107	0.0139	CbGeAlD
Valproic Acid—OGDH—blood—acquired immunodeficiency syndrome	0.00107	0.0138	CbGeAlD
Valproic Acid—OGDH—bone marrow—acquired immunodeficiency syndrome	0.00103	0.0133	CbGeAlD
Valproic Acid—OGDH—spinal cord—acquired immunodeficiency syndrome	0.00103	0.0133	CbGeAlD
Valproic Acid—UGT2B15—digestive system—acquired immunodeficiency syndrome	0.00101	0.013	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—acquired immunodeficiency syndrome	0.000999	0.0129	CbGeAlD
Valproic Acid—ABAT—retina—acquired immunodeficiency syndrome	0.000954	0.0123	CbGeAlD
Valproic Acid—HDAC9—blood—acquired immunodeficiency syndrome	0.00094	0.0121	CbGeAlD
Valproic Acid—OGDH—lung—acquired immunodeficiency syndrome	0.000935	0.0121	CbGeAlD
Valproic Acid—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.000913	0.0118	CbGeAlD
Valproic Acid—HDAC9—bone marrow—acquired immunodeficiency syndrome	0.00091	0.0118	CbGeAlD
Valproic Acid—ACADSB—digestive system—acquired immunodeficiency syndrome	0.000889	0.0115	CbGeAlD
Valproic Acid—UGT1A4—blood—acquired immunodeficiency syndrome	0.00087	0.0112	CbGeAlD
Valproic Acid—OGDH—nervous system—acquired immunodeficiency syndrome	0.000866	0.0112	CbGeAlD
Valproic Acid—ACADSB—blood—acquired immunodeficiency syndrome	0.000847	0.0109	CbGeAlD
Valproic Acid—OGDH—central nervous system—acquired immunodeficiency syndrome	0.000834	0.0108	CbGeAlD
Valproic Acid—HDAC9—lung—acquired immunodeficiency syndrome	0.000824	0.0106	CbGeAlD
Valproic Acid—ACADSB—bone marrow—acquired immunodeficiency syndrome	0.00082	0.0106	CbGeAlD
Valproic Acid—ACADSB—spinal cord—acquired immunodeficiency syndrome	0.000816	0.0105	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000793	0.0102	CbGeAlD
Valproic Acid—ACADSB—vagina—acquired immunodeficiency syndrome	0.000786	0.0101	CbGeAlD
Valproic Acid—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.000765	0.00988	CbGeAlD
Valproic Acid—HDAC9—nervous system—acquired immunodeficiency syndrome	0.000763	0.00986	CbGeAlD
Valproic Acid—ALDH5A1—blood—acquired immunodeficiency syndrome	0.000746	0.00964	CbGeAlD
Valproic Acid—ACADSB—lung—acquired immunodeficiency syndrome	0.000743	0.00959	CbGeAlD
Valproic Acid—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000739	0.00954	CbGeAlD
Valproic Acid—HDAC9—central nervous system—acquired immunodeficiency syndrome	0.000735	0.00949	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—acquired immunodeficiency syndrome	0.000722	0.00932	CbGeAlD
Valproic Acid—ALDH5A1—spinal cord—acquired immunodeficiency syndrome	0.000719	0.00928	CbGeAlD
Valproic Acid—HDAC2—retina—acquired immunodeficiency syndrome	0.000719	0.00928	CbGeAlD
Valproic Acid—ALDH5A1—vagina—acquired immunodeficiency syndrome	0.000692	0.00893	CbGeAlD
Valproic Acid—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000669	0.00863	CbGeAlD
Valproic Acid—OGDH—brain—acquired immunodeficiency syndrome	0.000662	0.00855	CbGeAlD
Valproic Acid—ALDH5A1—lung—acquired immunodeficiency syndrome	0.000654	0.00845	CbGeAlD
Valproic Acid—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000645	0.00833	CbGeAlD
Valproic Acid—OGDH—lymph node—acquired immunodeficiency syndrome	0.00064	0.00826	CbGeAlD
Valproic Acid—SLC16A1—retina—acquired immunodeficiency syndrome	0.000639	0.00825	CbGeAlD
Valproic Acid—ABAT—blood—acquired immunodeficiency syndrome	0.000638	0.00824	CbGeAlD
Valproic Acid—HDAC2—skin of body—acquired immunodeficiency syndrome	0.000631	0.00815	CbGeAlD
Valproic Acid—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000617	0.00796	CbGeAlD
Valproic Acid—ABAT—spinal cord—acquired immunodeficiency syndrome	0.000615	0.00794	CbGeAlD
Valproic Acid—ALDH5A1—nervous system—acquired immunodeficiency syndrome	0.000606	0.00782	CbGeAlD
Valproic Acid—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000604	0.0078	CbGeAlD
Valproic Acid—ABAT—vagina—acquired immunodeficiency syndrome	0.000592	0.00764	CbGeAlD
Valproic Acid—CYP2C18—vagina—acquired immunodeficiency syndrome	0.00059	0.00763	CbGeAlD
Valproic Acid—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000589	0.00761	CbGeAlD
Valproic Acid—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000586	0.00757	CbGeAlD
Valproic Acid—HDAC9—brain—acquired immunodeficiency syndrome	0.000584	0.00754	CbGeAlD
Valproic Acid—ALDH5A1—central nervous system—acquired immunodeficiency syndrome	0.000583	0.00753	CbGeAlD
Valproic Acid—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000582	0.00752	CbGeAlD
Valproic Acid—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000579	0.00747	CbGeAlD
Valproic Acid—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000573	0.0074	CbGeAlD
Valproic Acid—HDAC9—lymph node—acquired immunodeficiency syndrome	0.000564	0.00728	CbGeAlD
Valproic Acid—ABAT—lung—acquired immunodeficiency syndrome	0.00056	0.00723	CbGeAlD
Valproic Acid—ACADSB—brain—acquired immunodeficiency syndrome	0.000526	0.00679	CbGeAlD
Valproic Acid—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000523	0.00676	CbGeAlD
Valproic Acid—ABAT—nervous system—acquired immunodeficiency syndrome	0.000518	0.00669	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—acquired immunodeficiency syndrome	0.000511	0.0066	CbGeAlD
Valproic Acid—ACADSB—lymph node—acquired immunodeficiency syndrome	0.000508	0.00656	CbGeAlD
Valproic Acid—HDAC2—digestive system—acquired immunodeficiency syndrome	0.000505	0.00652	CbGeAlD
Valproic Acid—ABAT—central nervous system—acquired immunodeficiency syndrome	0.000499	0.00644	CbGeAlD
Valproic Acid—HDAC2—blood—acquired immunodeficiency syndrome	0.000481	0.00621	CbGeAlD
Valproic Acid—HDAC2—bone marrow—acquired immunodeficiency syndrome	0.000465	0.00601	CbGeAlD
Valproic Acid—ALDH5A1—brain—acquired immunodeficiency syndrome	0.000463	0.00598	CbGeAlD
Valproic Acid—SLC16A1—digestive system—acquired immunodeficiency syndrome	0.000448	0.00579	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—acquired immunodeficiency syndrome	0.000447	0.00578	CbGeAlD
Valproic Acid—HDAC2—vagina—acquired immunodeficiency syndrome	0.000446	0.00576	CbGeAlD
Valproic Acid—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000437	0.00564	CbGeAlD
Valproic Acid—HDAC2—lung—acquired immunodeficiency syndrome	0.000421	0.00544	CbGeAlD
Valproic Acid—SLC16A1—spinal cord—acquired immunodeficiency syndrome	0.000412	0.00532	CbGeAlD
Valproic Acid—ABAT—brain—acquired immunodeficiency syndrome	0.000396	0.00511	CbGeAlD
Valproic Acid—HDAC2—nervous system—acquired immunodeficiency syndrome	0.00039	0.00504	CbGeAlD
Valproic Acid—CYP2A6—vagina—acquired immunodeficiency syndrome	0.00039	0.00504	CbGeAlD
Valproic Acid—ABAT—lymph node—acquired immunodeficiency syndrome	0.000383	0.00494	CbGeAlD
Valproic Acid—HDAC2—central nervous system—acquired immunodeficiency syndrome	0.000376	0.00485	CbGeAlD
Valproic Acid—SLC16A1—lung—acquired immunodeficiency syndrome	0.000375	0.00484	CbGeAlD
Valproic Acid—CYP2A6—lung—acquired immunodeficiency syndrome	0.000369	0.00477	CbGeAlD
Valproic Acid—SLC22A5—retina—acquired immunodeficiency syndrome	0.000365	0.00471	CbGeAlD
Valproic Acid—SLC16A1—nervous system—acquired immunodeficiency syndrome	0.000347	0.00448	CbGeAlD
Valproic Acid—SLC22A7—brain—acquired immunodeficiency syndrome	0.000347	0.00448	CbGeAlD
Valproic Acid—SLC22A6—brain—acquired immunodeficiency syndrome	0.000335	0.00432	CbGeAlD
Valproic Acid—SLC16A1—central nervous system—acquired immunodeficiency syndrome	0.000334	0.00431	CbGeAlD
Valproic Acid—SLC22A8—blood—acquired immunodeficiency syndrome	0.000323	0.00417	CbGeAlD
Valproic Acid—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.00032	0.00414	CbGeAlD
Valproic Acid—HDAC2—brain—acquired immunodeficiency syndrome	0.000298	0.00385	CbGeAlD
Valproic Acid—HDAC2—lymph node—acquired immunodeficiency syndrome	0.000288	0.00372	CbGeAlD
Valproic Acid—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000284	0.00367	CbGeAlD
Valproic Acid—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000278	0.00359	CbGeAlD
Valproic Acid—CYP2C19—blood—acquired immunodeficiency syndrome	0.000271	0.0035	CbGeAlD
Valproic Acid—SLC16A1—brain—acquired immunodeficiency syndrome	0.000265	0.00342	CbGeAlD
Valproic Acid—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000262	0.00339	CbGeAlD
Valproic Acid—CYP2A6—brain—acquired immunodeficiency syndrome	0.000261	0.00337	CbGeAlD
Valproic Acid—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000256	0.00331	CbGeAlD
Valproic Acid—SLC16A1—lymph node—acquired immunodeficiency syndrome	0.000256	0.00331	CbGeAlD
Valproic Acid—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000252	0.00326	CbGeAlD
Valproic Acid—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000251	0.00325	CbGeAlD
Valproic Acid—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000251	0.00324	CbGeAlD
Valproic Acid—SLC22A5—blood—acquired immunodeficiency syndrome	0.000244	0.00315	CbGeAlD
Valproic Acid—CYP2C8—blood—acquired immunodeficiency syndrome	0.000236	0.00305	CbGeAlD
Valproic Acid—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000235	0.00304	CbGeAlD
Valproic Acid—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000232	0.003	CbGeAlD
Valproic Acid—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000226	0.00292	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000225	0.00291	CbGeAlD
Valproic Acid—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000224	0.00289	CbGeAlD
Valproic Acid—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000222	0.00287	CbGeAlD
Valproic Acid—CYP1A2—blood—acquired immunodeficiency syndrome	0.000221	0.00286	CbGeAlD
Valproic Acid—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00022	0.00285	CbGeAlD
Valproic Acid—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000219	0.00283	CbGeAlD
Valproic Acid—SLC22A5—lung—acquired immunodeficiency syndrome	0.000214	0.00276	CbGeAlD
Valproic Acid—CYP3A5—blood—acquired immunodeficiency syndrome	0.000213	0.00275	CbGeAlD
Valproic Acid—CYP2B6—blood—acquired immunodeficiency syndrome	0.000212	0.00274	CbGeAlD
Valproic Acid—CYP2C9—blood—acquired immunodeficiency syndrome	0.00021	0.00271	CbGeAlD
Valproic Acid—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000201	0.0026	CbGeAlD
Valproic Acid—SLC22A8—brain—acquired immunodeficiency syndrome	0.0002	0.00259	CbGeAlD
Valproic Acid—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000198	0.00255	CbGeAlD
Valproic Acid—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000196	0.00254	CbGeAlD
Valproic Acid—CYP1A2—lung—acquired immunodeficiency syndrome	0.000194	0.0025	CbGeAlD
Valproic Acid—PTGS1—blood—acquired immunodeficiency syndrome	0.000192	0.00247	CbGeAlD
Valproic Acid—CYP3A5—lung—acquired immunodeficiency syndrome	0.000187	0.00241	CbGeAlD
Valproic Acid—CYP2B6—lung—acquired immunodeficiency syndrome	0.000186	0.0024	CbGeAlD
Valproic Acid—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000185	0.00238	CbGeAlD
Valproic Acid—PTGS1—vagina—acquired immunodeficiency syndrome	0.000178	0.00229	CbGeAlD
Valproic Acid—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000172	0.00222	CbGeAlD
Valproic Acid—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000168	0.00217	CbGeAlD
Valproic Acid—PTGS1—lung—acquired immunodeficiency syndrome	0.000168	0.00217	CbGeAlD
Valproic Acid—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000166	0.00214	CbGeAlD
Valproic Acid—CYP3A4—blood—acquired immunodeficiency syndrome	0.00016	0.00207	CbGeAlD
Valproic Acid—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000156	0.00201	CbGeAlD
Valproic Acid—SLC22A5—brain—acquired immunodeficiency syndrome	0.000151	0.00196	CbGeAlD
Valproic Acid—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00015	0.00193	CbGeAlD
Valproic Acid—CYP2C8—brain—acquired immunodeficiency syndrome	0.000147	0.00189	CbGeAlD
Valproic Acid—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000146	0.00189	CbGeAlD
Valproic Acid—CYP2B6—brain—acquired immunodeficiency syndrome	0.000132	0.0017	CbGeAlD
Valproic Acid—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00013	0.00168	CbGeAlD
Valproic Acid—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000125	0.00162	CbGeAlD
Valproic Acid—PTGS1—brain—acquired immunodeficiency syndrome	0.000119	0.00154	CbGeAlD
Valproic Acid—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000115	0.00148	CbGeAlD
Valproic Acid—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	8.02e-05	0.000354	CcSEcCtD
Valproic Acid—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000353	CcSEcCtD
Valproic Acid—Chest pain—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000353	CcSEcCtD
Valproic Acid—Myalgia—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000353	CcSEcCtD
Valproic Acid—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.99e-05	0.000352	CcSEcCtD
Valproic Acid—Anaemia—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000352	CcSEcCtD
Valproic Acid—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.99e-05	0.000352	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.96e-05	0.000351	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.00035	CcSEcCtD
Valproic Acid—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.92e-05	0.000349	CcSEcCtD
Valproic Acid—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.92e-05	0.000349	CcSEcCtD
Valproic Acid—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.92e-05	0.000349	CcSEcCtD
Valproic Acid—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.92e-05	0.000349	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.91e-05	0.000349	CcSEcCtD
Valproic Acid—Cough—Saquinavir—acquired immunodeficiency syndrome	7.91e-05	0.000349	CcSEcCtD
Valproic Acid—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.000348	CcSEcCtD
Valproic Acid—Constipation—Indinavir—acquired immunodeficiency syndrome	7.86e-05	0.000347	CcSEcCtD
Valproic Acid—Pain—Indinavir—acquired immunodeficiency syndrome	7.86e-05	0.000347	CcSEcCtD
Valproic Acid—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.85e-05	0.000346	CcSEcCtD
Valproic Acid—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.85e-05	0.000346	CcSEcCtD
Valproic Acid—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.84e-05	0.000346	CcSEcCtD
Valproic Acid—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000345	CcSEcCtD
Valproic Acid—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000345	CcSEcCtD
Valproic Acid—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000345	CcSEcCtD
Valproic Acid—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.8e-05	0.000344	CcSEcCtD
Valproic Acid—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.8e-05	0.000344	CcSEcCtD
Valproic Acid—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.000344	CcSEcCtD
Valproic Acid—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.78e-05	0.000343	CcSEcCtD
Valproic Acid—Nausea—Didanosine—acquired immunodeficiency syndrome	7.78e-05	0.000343	CcSEcCtD
Valproic Acid—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.77e-05	0.000342	CcSEcCtD
Valproic Acid—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.76e-05	0.000342	CcSEcCtD
Valproic Acid—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.75e-05	0.000342	CcSEcCtD
Valproic Acid—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.000341	CcSEcCtD
Valproic Acid—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.74e-05	0.000341	CcSEcCtD
Valproic Acid—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.72e-05	0.00034	CcSEcCtD
Valproic Acid—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.00034	CcSEcCtD
Valproic Acid—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.00034	CcSEcCtD
Valproic Acid—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.00034	CcSEcCtD
Valproic Acid—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.69e-05	0.000339	CcSEcCtD
Valproic Acid—Oedema—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000339	CcSEcCtD
Valproic Acid—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.66e-05	0.000338	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.66e-05	0.000338	CcSEcCtD
Valproic Acid—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000337	CcSEcCtD
Valproic Acid—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000336	CcSEcCtD
Valproic Acid—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.57e-05	0.000334	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.57e-05	0.000334	CcSEcCtD
Valproic Acid—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.55e-05	0.000333	CcSEcCtD
Valproic Acid—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.54e-05	0.000333	CcSEcCtD
Valproic Acid—Cough—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000333	CcSEcCtD
Valproic Acid—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.54e-05	0.000333	CcSEcCtD
Valproic Acid—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.53e-05	0.000332	CcSEcCtD
Valproic Acid—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.52e-05	0.000332	CcSEcCtD
Valproic Acid—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.52e-05	0.000332	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.51e-05	0.000331	CcSEcCtD
Valproic Acid—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000331	CcSEcCtD
Valproic Acid—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.5e-05	0.000331	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.5e-05	0.000331	CcSEcCtD
Valproic Acid—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.49e-05	0.00033	CcSEcCtD
Valproic Acid—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.00033	CcSEcCtD
Valproic Acid—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.000329	CcSEcCtD
Valproic Acid—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.46e-05	0.000329	CcSEcCtD
Valproic Acid—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.46e-05	0.000329	CcSEcCtD
Valproic Acid—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000328	CcSEcCtD
Valproic Acid—Pain—Efavirenz—acquired immunodeficiency syndrome	7.43e-05	0.000327	CcSEcCtD
Valproic Acid—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.43e-05	0.000327	CcSEcCtD
Valproic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	7.42e-05	0.000327	CcSEcCtD
Valproic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.42e-05	0.000327	CcSEcCtD
Valproic Acid—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.41e-05	0.000327	CcSEcCtD
Valproic Acid—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.41e-05	0.000327	CcSEcCtD
Valproic Acid—Oedema—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000326	CcSEcCtD
Valproic Acid—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.39e-05	0.000326	CcSEcCtD
Valproic Acid—Headache—Nevirapine—acquired immunodeficiency syndrome	7.38e-05	0.000325	CcSEcCtD
Valproic Acid—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.36e-05	0.000325	CcSEcCtD
Valproic Acid—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.36e-05	0.000325	CcSEcCtD
Valproic Acid—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.36e-05	0.000325	CcSEcCtD
Valproic Acid—Infection—Saquinavir—acquired immunodeficiency syndrome	7.35e-05	0.000324	CcSEcCtD
Valproic Acid—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.33e-05	0.000323	CcSEcCtD
Valproic Acid—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000323	CcSEcCtD
Valproic Acid—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.000323	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.31e-05	0.000322	CcSEcCtD
Valproic Acid—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.3e-05	0.000322	CcSEcCtD
Valproic Acid—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000321	CcSEcCtD
Valproic Acid—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.00032	CcSEcCtD
Valproic Acid—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.00032	CcSEcCtD
Valproic Acid—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.25e-05	0.00032	CcSEcCtD
Valproic Acid—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.25e-05	0.00032	CcSEcCtD
Valproic Acid—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.24e-05	0.000319	CcSEcCtD
Valproic Acid—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.23e-05	0.000319	CcSEcCtD
Valproic Acid—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.22e-05	0.000319	CcSEcCtD
Valproic Acid—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.2e-05	0.000317	CcSEcCtD
Valproic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.19e-05	0.000317	CcSEcCtD
Valproic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.18e-05	0.000317	CcSEcCtD
Valproic Acid—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000317	CcSEcCtD
Valproic Acid—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.18e-05	0.000317	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000316	CcSEcCtD
Valproic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	7.17e-05	0.000316	CcSEcCtD
Valproic Acid—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.16e-05	0.000316	CcSEcCtD
Valproic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.16e-05	0.000316	CcSEcCtD
Valproic Acid—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.16e-05	0.000316	CcSEcCtD
Valproic Acid—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000315	CcSEcCtD
Valproic Acid—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.14e-05	0.000315	CcSEcCtD
Valproic Acid—Headache—Stavudine—acquired immunodeficiency syndrome	7.12e-05	0.000314	CcSEcCtD
Valproic Acid—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.12e-05	0.000314	CcSEcCtD
Valproic Acid—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000314	CcSEcCtD
Valproic Acid—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000313	CcSEcCtD
Valproic Acid—Pain—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000313	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.1e-05	0.000313	CcSEcCtD
Valproic Acid—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.09e-05	0.000313	CcSEcCtD
Valproic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	7.06e-05	0.000311	CcSEcCtD
Valproic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.06e-05	0.000311	CcSEcCtD
Valproic Acid—Oedema—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000311	CcSEcCtD
Valproic Acid—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000311	CcSEcCtD
Valproic Acid—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.05e-05	0.000311	CcSEcCtD
Valproic Acid—Headache—Abacavir—acquired immunodeficiency syndrome	7.02e-05	0.000309	CcSEcCtD
Valproic Acid—Infection—Lamivudine—acquired immunodeficiency syndrome	7.01e-05	0.000309	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	7e-05	0.000309	CcSEcCtD
Valproic Acid—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.99e-05	0.000308	CcSEcCtD
Valproic Acid—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.99e-05	0.000308	CcSEcCtD
Valproic Acid—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.95e-05	0.000306	CcSEcCtD
Valproic Acid—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.92e-05	0.000305	CcSEcCtD
Valproic Acid—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.91e-05	0.000305	CcSEcCtD
Valproic Acid—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.91e-05	0.000305	CcSEcCtD
Valproic Acid—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.9e-05	0.000304	CcSEcCtD
Valproic Acid—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.9e-05	0.000304	CcSEcCtD
Valproic Acid—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000303	CcSEcCtD
Valproic Acid—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000303	CcSEcCtD
Valproic Acid—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000302	CcSEcCtD
Valproic Acid—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.85e-05	0.000302	CcSEcCtD
Valproic Acid—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.85e-05	0.000302	CcSEcCtD
Valproic Acid—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.83e-05	0.000301	CcSEcCtD
Valproic Acid—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000301	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.79e-05	0.0003	CcSEcCtD
Valproic Acid—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.77e-05	0.000299	CcSEcCtD
Valproic Acid—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.77e-05	0.000299	CcSEcCtD
Valproic Acid—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000298	CcSEcCtD
Valproic Acid—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.76e-05	0.000298	CcSEcCtD
Valproic Acid—Nausea—Stavudine—acquired immunodeficiency syndrome	6.75e-05	0.000298	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000297	CcSEcCtD
Valproic Acid—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000297	CcSEcCtD
Valproic Acid—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000295	CcSEcCtD
Valproic Acid—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.68e-05	0.000295	CcSEcCtD
Valproic Acid—Nausea—Abacavir—acquired immunodeficiency syndrome	6.65e-05	0.000293	CcSEcCtD
Valproic Acid—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.64e-05	0.000293	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000293	CcSEcCtD
Valproic Acid—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000292	CcSEcCtD
Valproic Acid—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.6e-05	0.000291	CcSEcCtD
Valproic Acid—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.59e-05	0.000291	CcSEcCtD
Valproic Acid—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000291	CcSEcCtD
Valproic Acid—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000291	CcSEcCtD
Valproic Acid—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.57e-05	0.00029	CcSEcCtD
Valproic Acid—Pain—Ritonavir—acquired immunodeficiency syndrome	6.57e-05	0.00029	CcSEcCtD
Valproic Acid—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.57e-05	0.00029	CcSEcCtD
Valproic Acid—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.00029	CcSEcCtD
Valproic Acid—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.00029	CcSEcCtD
Valproic Acid—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.53e-05	0.000288	CcSEcCtD
Valproic Acid—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.51e-05	0.000287	CcSEcCtD
Valproic Acid—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.5e-05	0.000287	CcSEcCtD
Valproic Acid—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.000283	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000283	CcSEcCtD
Valproic Acid—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.4e-05	0.000282	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000282	CcSEcCtD
Valproic Acid—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000281	CcSEcCtD
Valproic Acid—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000281	CcSEcCtD
Valproic Acid—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.000279	CcSEcCtD
Valproic Acid—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.33e-05	0.000279	CcSEcCtD
Valproic Acid—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000279	CcSEcCtD
Valproic Acid—Pain—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000279	CcSEcCtD
Valproic Acid—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.29e-05	0.000277	CcSEcCtD
Valproic Acid—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.29e-05	0.000277	CcSEcCtD
Valproic Acid—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.28e-05	0.000277	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.000277	CcSEcCtD
Valproic Acid—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.27e-05	0.000277	CcSEcCtD
Valproic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	6.23e-05	0.000275	CcSEcCtD
Valproic Acid—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.23e-05	0.000275	CcSEcCtD
Valproic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.22e-05	0.000275	CcSEcCtD
Valproic Acid—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.21e-05	0.000274	CcSEcCtD
Valproic Acid—Headache—Zidovudine—acquired immunodeficiency syndrome	6.19e-05	0.000273	CcSEcCtD
Valproic Acid—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000271	CcSEcCtD
Valproic Acid—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.00027	CcSEcCtD
Valproic Acid—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.12e-05	0.00027	CcSEcCtD
Valproic Acid—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000269	CcSEcCtD
Valproic Acid—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.09e-05	0.000269	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000269	CcSEcCtD
Valproic Acid—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.08e-05	0.000268	CcSEcCtD
Valproic Acid—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.08e-05	0.000268	CcSEcCtD
Valproic Acid—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000268	CcSEcCtD
Valproic Acid—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000268	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.05e-05	0.000267	CcSEcCtD
Valproic Acid—Pain—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000266	CcSEcCtD
Valproic Acid—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000266	CcSEcCtD
Valproic Acid—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.96e-05	0.000263	CcSEcCtD
Valproic Acid—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.94e-05	0.000262	CcSEcCtD
Valproic Acid—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.88e-05	0.000259	CcSEcCtD
Valproic Acid—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000259	CcSEcCtD
Valproic Acid—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.87e-05	0.000259	CcSEcCtD
Valproic Acid—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.85e-05	0.000258	CcSEcCtD
Valproic Acid—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.85e-05	0.000258	CcSEcCtD
Valproic Acid—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.84e-05	0.000258	CcSEcCtD
Valproic Acid—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.81e-05	0.000256	CcSEcCtD
Valproic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	5.79e-05	0.000256	CcSEcCtD
Valproic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.79e-05	0.000255	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.77e-05	0.000254	CcSEcCtD
Valproic Acid—Headache—Indinavir—acquired immunodeficiency syndrome	5.76e-05	0.000254	CcSEcCtD
Valproic Acid—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.74e-05	0.000253	CcSEcCtD
Valproic Acid—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.68e-05	0.000251	CcSEcCtD
Valproic Acid—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.00025	CcSEcCtD
Valproic Acid—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000247	CcSEcCtD
Valproic Acid—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000246	CcSEcCtD
Valproic Acid—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000246	CcSEcCtD
Valproic Acid—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000243	CcSEcCtD
Valproic Acid—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.51e-05	0.000243	CcSEcCtD
Valproic Acid—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.49e-05	0.000242	CcSEcCtD
Valproic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000241	CcSEcCtD
Valproic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000241	CcSEcCtD
Valproic Acid—Nausea—Indinavir—acquired immunodeficiency syndrome	5.46e-05	0.000241	CcSEcCtD
Valproic Acid—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.45e-05	0.00024	CcSEcCtD
Valproic Acid—Headache—Efavirenz—acquired immunodeficiency syndrome	5.44e-05	0.00024	CcSEcCtD
Valproic Acid—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.44e-05	0.00024	CcSEcCtD
Valproic Acid—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.31e-05	0.000234	CcSEcCtD
Valproic Acid—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.000233	CcSEcCtD
Valproic Acid—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.26e-05	0.000232	CcSEcCtD
Valproic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	5.24e-05	0.000231	CcSEcCtD
Valproic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000231	CcSEcCtD
Valproic Acid—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000231	CcSEcCtD
Valproic Acid—Headache—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.00023	CcSEcCtD
Valproic Acid—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.2e-05	0.000229	CcSEcCtD
Valproic Acid—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.16e-05	0.000227	CcSEcCtD
Valproic Acid—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.08e-05	0.000224	CcSEcCtD
Valproic Acid—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000223	CcSEcCtD
Valproic Acid—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.06e-05	0.000223	CcSEcCtD
Valproic Acid—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.00022	CcSEcCtD
Valproic Acid—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.93e-05	0.000218	CcSEcCtD
Valproic Acid—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.89e-05	0.000216	CcSEcCtD
Valproic Acid—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.88e-05	0.000215	CcSEcCtD
Valproic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000214	CcSEcCtD
Valproic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000213	CcSEcCtD
Valproic Acid—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.83e-05	0.000213	CcSEcCtD
Valproic Acid—Headache—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000212	CcSEcCtD
Valproic Acid—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000207	CcSEcCtD
Valproic Acid—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.66e-05	0.000206	CcSEcCtD
Valproic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000206	CcSEcCtD
Valproic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000205	CcSEcCtD
Valproic Acid—Headache—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000204	CcSEcCtD
Valproic Acid—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.56e-05	0.000201	CcSEcCtD
Valproic Acid—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000198	CcSEcCtD
Valproic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	4.45e-05	0.000196	CcSEcCtD
Valproic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000196	CcSEcCtD
Valproic Acid—Headache—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000195	CcSEcCtD
Valproic Acid—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.39e-05	0.000194	CcSEcCtD
Valproic Acid—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.19e-05	0.000185	CcSEcCtD
